Congratulations to Bristol Myers Squibb!

Global biopharmaceutical giant Bristol Myers Squibb is focused on developing innovative medicines that address the unmet needs of patients with serious diseases. Clinical trials are key to the company’s research and development (R&D) process. Teams internal to Bristol Myers Squibb conduct some of these studies, while external clinical research organizations (CROs) handle others. Either way, insurance is a prerequisite before any clinical trial can get under way.

“Clinical trial insurance protects participants, covering expenses in the event that a patient sustains injuries during the trial,” explains Henry Huseby, director, corporate insurances. “The unique challenge for a global pharma company is that every country requires you to have clinical trial insurance, but no two countries are the same. The insurance you buy in Romania is completely different from what you buy in Australia.”

Bristol Myers Squibb must submit documentation to each nation’s ethics committee, Ministry of Health, or other agency, as dictated by local law. In addition to proof of insurance, these submissions include details such as the title of the study, number of patients, purpose of the trial, and testing sites (in some jurisdictions). Some countries require all this information to be submitted in the local language.

Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.

Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.

Already have an account?


NOT FOR REPRINT

© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Meg Waters

Meg Waters is the editor in chief of Treasury & Risk. She is the former editor in chief of BPM Magazine and the former managing editor of Business Finance.

More from this author

Dig Deeper

 

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2023 ALM Global, LLC. All Rights Reserved.